Skip to main content

and
  1. Article

    Open Access

    Perceived patient burden and acceptability of MRI in comparison to PSA and ultrasound: results from the IP1-PROSTAGRAM study

    The IP1-PROSTAGRAM study showed that a short, non-contrast MRI detected more significant cancers with similar rates of biopsy compared to PSA. Herein, we compare the expected and perceived burden of PSA, MRI a...

    David Eldred-Evans, Mathias Winkler in Prostate Cancer and Prostatic Diseases (2023)

  2. No Access

    Article

    Landmarks in the evolution of prostate biopsy

    Approaches and techniques used for diagnostic prostate biopsy have undergone considerable evolution over the past few decades: from the original finger-guided techniques to the latest MRI-directed strategies, ...

    Martin J. Connor, Michael A. Gorin, David Eldred-Evans in Nature Reviews Urology (2023)

  3. Article

    Open Access

    Adjusting for verification bias in diagnostic accuracy measures when comparing multiple screening tests - an application to the IP1-PROSTAGRAM study

    Novel screening tests used to detect a target condition are compared against either a reference standard or other existing screening methods. However, as it is not always possible to apply the reference standa...

    Emily Day, David Eldred-Evans, A. Toby Prevost in BMC Medical Research Methodology (2022)

  4. No Access

    Article

    Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study

    Focal therapy (FT) ablates areas of prostate cancer rather than treating the whole gland. We compared oncological outcomes of FT to radical prostatectomy (RP).

    Taimur T. Shah, Deepika Reddy, Max Peters in Prostate Cancer and Prostatic Diseases (2021)

  5. No Access

    Article

    Rethinking prostate cancer screening: could MRI be an alternative screening test?

    In the past decade rigorous debate has taken place about population-based screening for prostate cancer. Although screening by serum PSA levels can reduce prostate cancer-specific mortality, it is unclear whet...

    David Eldred-Evans, Henry Tam, Heminder Sokhi, Anwar R. Padhani in Nature Reviews Urology (2020)

  6. Article

    Open Access

    Use of Imaging to Optimise Prostate Cancer Tumour Volume Assessment for Focal Therapy Planning

    Rapid advances in imaging of the prostate have facilitated the development of focal therapy and provided a non-invasive method of estimating tumour volume. Focal therapy relies on an accurate estimate of tumou...

    David Eldred-Evans, Henry Tam, Andrew P. T. Smith in Current Urology Reports (2020)

  7. Article

    Open Access

    A prospective analysis of robotic targeted MRI-US fusion prostate biopsy using the centroid targeting approach

    Robotic prostate biopsy is an emerging technology. Recent development of this tool has allowed the performance of a transperineal prostate biopsy allowing pre-programmed standardized biopsy schemes. Prospectiv...

    Saiful Miah, Pol Servian, Amit Patel, Catherine Lovegrove in Journal of Robotic Surgery (2020)

  8. No Access

    Article

    Diagnostic value of MRI-based PSA density in predicting transperineal sector-guided prostate biopsy outcomes

    Prostate-specific antigen (PSA) density (PSAD) has potential to increase the diagnostic utility of PSA, yet has had poor uptake in clinical practice. We aimed to determine the diagnostic value of magnetic reso...

    Findlay MacAskill, Su-Min Lee, David Eldred-Evans in International Urology and Nephrology (2017)